TIDM0Y7T TIDMIRSH TIDMBARC
FORM 8.3 Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in ALLERGAN PLC
Class of relevant security to which the dealings being ORD
disclosed relate (Note 2)
Date of dealing 07 May 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,721,579 1.13% 2,948,434 0.90%
(2) Derivatives (other than options):
2,887,345 0.88% 2,368,331 0.72%
(3) Options and agreements to
purchase/sell: 180,100 0.05% 132,400 0.04%
TOTAL:
6,789,024 2.06% 5,449,165 1.66%
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 5 193.6620 USD
Purchase 11 194.0272 USD
Purchase 23 194.0821 USD
Purchase 51 193.4796 USD
Purchase 81 193.7839 USD
Purchase 90 193.6885 USD
Purchase 90 193.1600 USD
Purchase 100 194.3400 USD
Purchase 100 193.1370 USD
Purchase 107 194.2027 USD
Purchase 139 193.6184 USD
Purchase 163 193.8120 USD
Purchase 200 194.5650 USD
Purchase 205 194.6800 USD
Purchase 300 193.6916 USD
Purchase 300 194.1333 USD
Purchase 302 194.6300 USD
Purchase 485 193.9377 USD
Purchase 600 194.0383 USD
Purchase 665 193.4400 USD
Purchase 700 193.9528 USD
Purchase 800 193.9903 USD
Purchase 801 193.2304 USD
Purchase 954 194.0824 USD
Purchase 1,000 194.2020 USD
Purchase 1,065 194.2782 USD
Purchase 1,193 193.4752 USD
Purchase 1,217 192.9900 USD
Purchase 1,298 194.5891 USD
Purchase 1,400 193.9150 USD
Purchase 1,516 193.4454 USD
Purchase 1,707 194.1787 USD
Purchase 1,800 194.5933 USD
Purchase 2,031 193.9919 USD
Purchase 2,100 193.5519 USD
Purchase 2,206 193.1704 USD
Purchase 2,551 194.0888 USD
Purchase 2,570 193.4375 USD
Purchase 2,900 193.7410 USD
Purchase 3,604 193.2499 USD
Purchase 4,400 193.3165 USD
Purchase 4,661 193.7948 USD
Purchase 4,756 193.9011 USD
Purchase 5,000 194.4882 USD
Purchase 5,399 193.4926 USD
Purchase 5,600 193.0981 USD
Purchase 5,801 192.9947 USD
Purchase 6,928 195.2700 USD
Purchase 7,210 193.1583 USD
Purchase 8,100 194.3551 USD
Purchase 8,600 193.3173 USD
Purchase 10,047 193.8792 USD
Purchase 10,874 193.1114 USD
Purchase 11,692 194.4695 USD
Purchase 13,293 193.3710 USD
Purchase 16,150 193.2010 USD
Purchase 16,250 193.2507 USD
Purchase 20,000 193.6808 USD
Purchase 30,713 193.7068 USD
Purchase 57,515 193.4586 USD
Purchase 177,915 193.4773 USD
Sale 2 192.7400 USD
Sale 32 193.3993 USD
Sale 37 192.5800 USD
Sale 54 193.7305 USD
Sale 75 192.9700 USD
Sale 100 194.5100 USD
Sale 100 194.4000 USD
Sale 100 194.0800 USD
Sale 100 193.5700 USD
Sale 100 193.3000 USD
Sale 100 193.9928 USD
Sale 101 193.0700 USD
Sale 200 193.2400 USD
Sale 200 193.1525 USD
Sale 200 193.1100 USD
Sale 200 193.1250 USD
Sale 200 193.9600 USD
Sale 215 192.7300 USD
Sale 250 193.6205 USD
Sale 400 194.2087 USD
Sale 446 194.5222 USD
Sale 468 194.6600 USD
Sale 502 193.8426 USD
Sale 597 193.7531 USD
Sale 600 194.6183 USD
Sale 604 193.6296 USD
Sale 782 194.5250 USD
Sale 802 192.9404 USD
Sale 823 193.4403 USD
Sale 1,001 193.5482 USD
Sale 1,509 192.6612 USD
Sale 2,050 193.1363 USD
Sale 2,100 193.5307 USD
Sale 3,409 193.4447 USD
Sale 3,600 194.5933 USD
Sale 4,460 193.0215 USD
Sale 6,960 195.2700 USD
Sale 7,212 192.9900 USD
Sale 11,500 194.2414 USD
Sale 12,246 193.6118 USD
Sale 17,505 193.6830 USD
Sale 19,100 193.3838 USD
Sale 19,244 193.8892 USD
Sale 30,773 193.4977 USD
Sale 50,000 194.0969 USD
Sale 93,145 193.2599 USD
Sale 174,564 193.4695 USD
(b) Derivatives transactions (other than options
transactions)
Product name, Nature of transaction Number of relevant Price per unit
e.g. CFD (Note 6) securities (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant
securities
(i) Writing, selling, purchasing or varying
Product Writing, Number Exercise Type Expiry Option
Name
purchasing, of price date money
selling, securities paid/
varying etc to which received
option
relates
Put Purchasing 600 170 USD American 15 May 0.0100 USD
Option 2020
Put Selling 2,900 150 USD American 15 Jan 0.3255 USD
Option 2021
Put Selling 2,000 190 USD American 15 May 0.4350 USD
Option 2020
Product Writing, Number of Exercise Type, Expiry Option money
name, selling, securities price e.g. date paid/received
e.g. purchasing, to which American, per unit
call varying the option European (Note 5)
option etc. relates etc.
(Note 7)
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 11 May 2020
Contact name Large Holdings Regulatory Operations
Telephone number 020 3134 7213
If a connected EFM, name of
offeree/offeror with which connected
If a connected EFM, state nature of
connection (Note 10)
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
relevant
purchased securities price date
to which the
option
or derivative
relates
Call Options Purchased 600 175.0000 American Jan 15, 2021
Put Options Written 200 190.0000 American Aug 21, 2020
Call Options Purchased 6,400 185.0000 American Jan 15, 2021
Call Options Written -1,400 230.0000 American Jun 19, 2020
Call Options Written -1,500 220.0000 American Aug 21, 2020
Put Options Purchased -4,500 70.0000 American Jan 15, 2021
Put Options Written 43,900 105.0000 American Jan 15, 2021
Put Options Written 8,200 150.0000 American May 15, 2020
Call Options Purchased 6,400 175.0000 American May 15, 2020
Put Options Purchased -16,500 115.0000 American Jan 15, 2021
Put Options Purchased -1,200 65.0000 American Jan 15, 2021
Call Options Written -42,500 165.0000 American Jan 21, 2022
Call Options Written -1,100 200.0000 American Aug 21, 2020
Call Options Purchased 32,500 175.0000 American Jan 21, 2022
Call Options Purchased 9,500 170.0000 American Jun 19, 2020
Call Options Purchased 500 165.0000 American Jan 15, 2021
Call Options Purchased 1,200 190.0000 American May 15, 2020
Put Options Purchased -5,100 170.0000 American Jan 15, 2021
Put Options Purchased -1,000 195.0000 American May 15, 2020
Call Options Purchased 1,700 170.0000 American May 15, 2020
Put Options Written 33,200 140.0000 American Jun 19, 2020
Put Options Purchased -2,600 75.0000 American Jan 15, 2021
Put Options Purchased -900 175.0000 American Aug 21, 2020
Put Options Purchased -6,300 170.0000 American Jun 19, 2020
Put Options Written 600 150.0000 American Jun 19, 2020
Call Options Purchased 4,400 190.0000 American Jan 15, 2021
Put Options Written 6,700 140.0000 American Jan 15, 2021
Put Options Purchased -29,400 150.0000 American Jan 15, 2021
Call Options Written -7,200 260.0000 American Jan 15, 2021
Put Options Written 100 165.0000 American May 15, 2020
Call Options Purchased 3,400 160.0000 American Jan 15, 2021
Put Options Written 2,700 180.0000 American May 15, 2020
Put Options Purchased -900 185.0000 American Jan 15, 2021
Put Options Purchased -2,400 160.0000 American Jan 15, 2021
Call Options Purchased 600 150.0000 American Jan 15, 2021
Put Options Written 3,700 215.0000 American Jan 15, 2021
Put Options Purchased -7,200 180.0000 American Jan 15, 2021
Put Options Purchased -600 185.0000 American May 15, 2020
Call Options Purchased 9,100 195.0000 American Jan 15, 2021
Put Options Written 4,500 195.0000 American Aug 21, 2020
Put Options Purchased -100 195.0000 American Jun 19, 2020
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be given on this form.
2. For all prices and other monetary amounts, the currency must
be stated.
For full details of disclosure requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20200511005749/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC
Copyright Business Wire 2020
(END) Dow Jones Newswires
May 11, 2020 12:34 ET (16:34 GMT)
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
